Related Experiment Videos
Evaluation and therapy of chronic interstitial pneumonitis in children
1National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado.
Insights
Interstitial pneumonias in children are rare, serious lung diseases. Diagnosis is improving with advanced imaging and biopsies, while treatments and lung transplants offer hope for better outcomes.
Area of Science:
- Pediatric Pulmonology
- Rare Diseases
- Critical Care Medicine
Background:
- Interstitial pneumonias in children represent a spectrum of uncommon lung diseases.
- These conditions carry significant rates of illness and death in pediatric populations.
- Diagnosis has been historically challenging, impacting timely and effective management.
Purpose of the Study:
- To review current diagnostic and therapeutic strategies for pediatric interstitial pneumonias.
- To highlight advancements in diagnostic modalities and their clinical utility.
- To discuss the evolving role of lung transplantation in managing end-stage disease.
Main Methods:
- Review of recent literature on pediatric interstitial pneumonias.
- Analysis of diagnostic advancements including high-resolution computed tomography (HRCT) and bronchoalveolar lavage (BAL).
- Evaluation of open lung biopsy and thoracoscopic approaches, alongside current treatment protocols and transplantation outcomes.
Main Results:
- High-resolution computed tomography and bronchoalveolar lavage have enhanced diagnostic accuracy.
- Open lung biopsy remains a key diagnostic tool, with thoracoscopic methods showing promise in children.
- Empirical treatments (corticosteroids, hydroxychloroquine, cytotoxic agents) lack controlled trial data.
- Lung transplantation is increasingly successful, even in infants with end-stage disease.
Conclusions:
- Improved diagnostic tools are aiding in the identification of pediatric interstitial pneumonias.
- Current treatment strategies are largely empirical, underscoring the need for therapeutic research.
- Lung transplantation offers a viable option for select pediatric patients with severe, end-stage lung disease.
Abstract:
The interstitial pneumonias in children are a diverse group of rare conditions associated with considerable morbidity and mortality. Newer diagnostic modalities such as high-resolution computed tomography and bronchoalveolar lavage have improved the ability to diagnose these conditions. Open lung biopsy remains the most useful diagnostic study, and thoracoscopic methods are being used in children more frequently with favorable results. Treatment with corticosteroids, hydroxychloroquine, and cytotoxic agents is empirical due to a lack of controlled therapeutic trials. Lung transplantation, even in infants, is being done more often and with greater success for end-stage lung disease.